COMBINATION OF XENON AND AN ANTIOXIDANT TO CONTROL A PARKINSON'S DISEASE-TYPE NEURODEGENERATIVE DISEASE
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
May 12, 2015
filing date -
May 21, 2014
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The invention relates to a drug combination including xenon gas and at least one antioxidant, in liquid or solid form, for use in treating, slowing, or preventing neurological damage following a neurodegenerative disease in a human being. Preferably, the xenon content is 10% to 80% by volume. Also, the antioxidant is preferably vitamin E, a vitamin E analog, or a vitamin E derivative. The neurodegenerative disease is Parkinson's disease or a disease related to Parkinson's disease.
First Claim
Other Claims data not available